CV SCIENCES, INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$3M
↓-14.9% -$577Kvs FY2024 (Q4)
Gross Profit
$2M
↓-0.4% -$6Kvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $3M | $4M |
| COGS | $2M | $2M |
| Gross Profit | $2M | $2M |
| R&D | $18K | $25K |
| SG&A | $2M | $2M |
| D&A | $21K | $114K |
| Other OpEx | $0 | $0 |
| Operating Income | $0 | $0 |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · CVSI · Comparing FY2025 (Q4) vs FY2024 (Q4)